4.2.2Segment

Addiction & Substance Use Treatment

Residential, outpatient, and medication-assisted treatment programs serving individuals with alcohol, opioid, and substance use disorders.

5
Verticals

Overview

Addiction & Substance Use Treatment covers residential, outpatient, and medication-assisted treatment (MAT) programs for alcohol, opioid, and substance-use disorders. Demand has been driven by the opioid and broader addiction crisis, and MAT (methadone, buprenorphine) has expanded access to evidence-based care.

Private equity has consolidated treatment providers (BayMark, Pinnacle, and others), but the sector has a fraught history — patient-brokering scandals, quality concerns, and reimbursement volatility — that shapes both regulation and reputational risk. Demand remains high and structural.

Market snapshot

FragmentationConsolidating

No single discrete Census NAICS code — addiction treatment spans outpatient centers (621420), residential (623220), and hospitals (622210), so the segment is not separately sized by the Census Bureau.

Business model & economics

Revenue model
Per-diem residential, outpatient, and MAT reimbursement
Recurring revenue
Moderate–High — recurring MAT and outpatient care
EBITDA margin
12–22%
Capex intensity
Moderate
  • Demand driven by the opioid and addiction crisis.
  • MAT expanded evidence-based, recurring treatment.
  • Fraught history of scandals and quality concerns.

M&A deal context

High deal activity

Who’s acquiring

PE-backed treatment platformsMAT and outpatient consolidatorsBehavioral-health operators

What’s driving deals

  • Consolidation of treatment providers.
  • Opioid-crisis and addiction demand.
  • Regulatory and reputational scrutiny.

Verticals in this segment

  • 4.2.2.1Detox & Medical Withdrawal Programs

    Medically supervised detoxification and withdrawal management services.

  • 4.2.2.2Intensive Outpatient Programs (IOP)

    Outpatient treatment programs providing 9+ hours of weekly structured care.

  • 4.2.2.3Medication-Assisted Treatment (MAT)

    Programs using buprenorphine, methadone, or naltrexone for addiction treatment.

  • 4.2.2.4Partial Hospitalization Programs (PHP)

    Day treatment programs providing 20+ hours of weekly clinical services.

  • 4.2.2.5Residential Substance Use Programs

    Residential treatment facilities providing 24-hour addiction recovery care.

Find Addiction & Substance Use Treatment acquisition targets

Search Acquisera’s index for companies classified under Addiction & Substance Use Treatment (4.2.2) and build a targeted deal pipeline.

Search companies